Xin Li | Biomaterials | Best Researcher Award

Posted on by sciencefather

Dr. Xin Li | Biomaterials | Best Researcher Award

Dr. Xin Li , The Chinese University of Hong Kong , Hong Kong

Dr. Xin Li is a dynamic and prolific researcher in the field of biomedical polymer materials and nanomedicine. With a Ph.D. from RWTH Aachen University under the mentorship of Prof. Andrij Pich, Dr. Li has carved a niche in responsive nanogels, ultrasound-triggered drug delivery, and smart biosensors. He currently holds a position as a Research Associate at The Chinese University of Hong Kong, following a postdoctoral fellowship at HKUST. Dr. Li has published over 70 SCI-indexed papers, earned 2600+ citations, holds 10 patents, and contributed to one academic book. His research stands out in top-tier journals like Nature Communications, Chem, Matter, and Advanced Materials. Recognized globally, he has led several high-impact research projects and received prestigious honors such as the 2024 JPA Prize and the 2021 Young Scientist Award. Dr. Li’s innovative mindset and cross-disciplinary expertise continue to push boundaries in biomedical engineering.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Outstanding Publication Record 📚
    Dr. Li has authored over 70 SCI-indexed publications in top-tier journals such as Nature Communications, Chem, Matter, Advanced Materials, and Angewandte Chemie. With an H-index of 32 and 2600+ citations, he demonstrates a strong impact in his field.

  2. Innovative and Translational Research 💡
    His work focuses on stimuli-responsive nanogels, mechanophore-based drug delivery, and biosensors, directly addressing real-world medical challenges like cancer therapy and infection monitoring.

  3. Leadership in International Projects 🌏
    Dr. Li has served as Principal Investigator and Co-leader of prestigious funding programs, including the Shanghai Overseas High-level Young Talent Program, Pujiang Program, and a Sino-German Research Grant, totaling over ¥1 million and €257,000.

  4. Interdisciplinary Expertise 🔬
    With a background in polymeric materials, biomedical engineering, and biophysics, he bridges the gap between material science and clinical applications, pushing the boundaries of modern nanomedicine.

  5. Recognized Honors and Editorial Roles 🏆
    Awards like the 2024 JPA Prize and the 2021 Young Scientist Award, along with his editorial contributions, highlight both his recognition and thought leadership in the scientific community.

⚠️ Areas for Improvement:

  1. Broader Industry Collaboration
    While Dr. Li has a strong academic and funding track record, increasing collaboration with biotech or pharmaceutical industries could further enhance the translational value of his research.

  2. Public Engagement and Science Communication
    As his work involves complex and novel biomedical technologies, more active engagement in science communication or public-facing platforms could broaden the reach and societal impact of his innovations.

  3. Diversified International Experience
    Though already globally active (Germany, China, Hong Kong), involvement in North American or broader EU collaborative networks might further strengthen his research diversity and global visibility.

🎓 Education:

Dr. Xin Li holds a Ph.D. in Biomedical Polymer Materials from RWTH Aachen University, Germany (2018–2023), where he worked under Prof. Andrij Pich, focusing on functional nanogels and stimuli-responsive systems for precise therapy. Prior to this, he earned an M.S. in Biomedical Engineering from Donghua University (2014–2017), supervised by Prof. Xiangyang Shi, with work centered around nanomaterials for gene and drug delivery. His academic journey began with a B.E. in Polymeric Materials and Engineering from Zhejiang A & F University (2010–2014), mentored by Prof. Pingan Song and Prof. Liang Chen. Across each academic stage, Dr. Li demonstrated an impressive aptitude for interdisciplinary innovation, combining materials science, chemical engineering, and biomedical applications. His strong educational foundation set the stage for his successful research career in developing next-generation nanomedicines and imaging technologies.

💼 Experience:

Dr. Xin Li currently serves as a Research Associate at The Chinese University of Hong Kong (2024–present), advancing cutting-edge research in nanomedicine. Prior to this, he was a Postdoctoral Fellow at The Hong Kong University of Science and Technology (2023–2024), where he expanded his expertise in responsive nanomaterials. His earlier research assistant roles at the DWI-Leibniz Institute (2022–2023) and Donghua University (2017) enriched his multidisciplinary experience. During his doctoral training at RWTH Aachen, Dr. Li led multiple collaborations and mentored students, reflecting his leadership potential. He has independently secured and led major grants like the Shanghai Overseas High-level Young Talent Program and the Pujiang Program. Dr. Li’s professional trajectory demonstrates a steady rise marked by impactful research, international collaboration, and continuous innovation in materials for imaging, therapy, and diagnostics.

🏅 Awards and Honors:

Dr. Xin Li has been consistently recognized for his contributions to biomedical engineering and nanomedicine. In 2024, he received the JPA Prize for his role as an Excellent Young Editorial Board Member. Earlier, in 2021, he was honored with the Young Scientist Award at the 3rd Global Experts Meeting on Chemistry and Medicinal Chemistry, acknowledging his innovative research in responsive drug delivery systems. He also earned the CSC-RWTH Scholarship in 2017, awarded by the China Scholarship Council for his doctoral studies in Germany, reflecting academic excellence and international research promise. In addition to these accolades, he has been entrusted with leadership roles in competitive grant programs such as the Shanghai Overseas High-level Talent Plan and the Sino-German Center collaborative research grant. These honors highlight Dr. Li’s status as an emerging leader in translational nanomedicine and interdisciplinary biomedical research.

🔬 Research Focus:

Dr. Xin Li’s research focuses on the design and development of stimuli-responsive nanogels, ultrasound-activated drug delivery systems, and smart biosensors. He is particularly interested in leveraging physical triggers (e.g., ultrasound, radiotherapy) to enable precise drug activation, offering high specificity and minimal side effects. His work on polymer mechanochemistry and hydrogel-based biosensors has opened new frontiers in non-invasive cancer therapy, infection monitoring, and imaging. With a deep understanding of polymer physics, biomedical engineering, and nanotechnology, Dr. Li integrates multiple disciplines to tackle challenges in tumor-targeted delivery, photothermal therapy, and metabolic reprogramming. His future focus includes developing clinically translatable systems for real-time therapy monitoring, immune modulation, and personalized medicine. By combining fundamental research with practical applications, Dr. Li aims to revolutionize how diseases like cancer and infections are diagnosed and treated.

📚 Publications Top Notes:

  1. 🧬 Transvascular transport of nanocarriers for tumor delivery, Nat. Commun., 2024

  2. 🧠 Leukocyte-nanomedicine system for targeted delivery and precise theragnostics, Chem, 2022

  3. 🩹 A wireless and battery-free DNA hydrogel biosensor for wound infection monitoring, Matter, 2022

  4. 💊 Radiotherapy-triggered prodrug activation: A new era in precise chemotherapy, Med, 2022

  5. 🧪 Engineered living hydrogels for robust biocatalysis in pure organic solvents, Cell Rep. Phys. Sci., 2022

  6. ☢️ Radiotherapy activated systems for precise tumor treatment, Nat. Rev. Cancer, 2025

  7. 💧 Sprayed aqueous microdroplets for spontaneous synthesis of functional microgels, Angew. Chem. Int. Ed., 2025

  8. 🧬 Functional dendrimer nanogels for DNA delivery and gene therapy of tumors, Angew. Chem. Int. Ed., 2025

  9. 🔥 Global cold local photothermal-mediated synergistic metabolic antitumor immunity, Adv. Mater., 2025

  10. 📡 Network topology of nanogels regulates mechanophore activation for ultrasound-mediated therapy, Angew. Chem. Int. Ed., 2025

🧾 Conclusion:

Dr. Xin Li is highly suitable and deserving of the Best Researcher Award. His exceptional research output, innovative project leadership, and contributions to translational biomedical science place him among the leading young researchers globally. While there is room for expanding industry ties and global engagement, his trajectory, impact, and recognition already demonstrate excellence well above typical benchmarks. Dr. Li exemplifies the future of interdisciplinary research and is a valuable asset to the global scientific community.

Zhirong Tan | Gene Regulation Epigenetics | Best Researcher Award

Posted on by sciencefather

Prof. Zhirong Tan | Gene Regulation Epigenetics | Best Researcher Award

Prof. Zhirong Tan  , Xiangya Hospital, Central South University , China

Professor Zhirong Tan is a leading Chinese expert in pharmacogenomics and clinical pharmacology. Currently a professor at Xiangya Hospital, Central South University, he also serves as the Director of the Pharmacogenetics and Pharmacokinetics Research Laboratory and Deputy Director of the Drug Analysis Center. He has been instrumental in over 300 clinical trials, pushing forward the frontiers of precision medicine, especially in colorectal cancer and Alzheimer’s disease. With over 20 SCI papers, multiple patents, and co-authorship of four books, he’s widely recognized for his work in pharmacokinetics and biomarker discovery. A national GCP and GMP inspector, Prof. Tan actively contributes to pharmaceutical regulation and innovation in China. His academic and industry partnerships reflect a robust foundation in translational research and real-world drug development.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Extensive Research Contributions
    Prof. Zhirong Tan has made outstanding contributions to clinical pharmacology, pharmacogenetics, and metabolomics over two decades. His research has provided critical insights into drug metabolism, biomarker discovery, and precision medicine, especially in colorectal cancer and Alzheimer’s disease.

  2. Prolific Publication Record
    With over 22 SCI-indexed publications (first or corresponding author) and 6 CSCD papers, Prof. Tan’s research has achieved over 3550 citations and an H-index of 33 on Web of Science—evidence of the high impact and recognition of his work.

  3. Strong National & Industry Collaborations
    He has participated in or led 300+ clinical trials and secured 5 “Million+” industry-funded projects, reflecting strong ties with both academia and industry. His leadership in national-level projects, such as the “Major New Drug Development” program, showcases his influence in China’s healthcare innovation.

  4. Intellectual Property and Innovation
    With 3 granted patents and 3 under review, Prof. Tan’s ability to translate research into practical applications is evident. His individualized esomeprazole dosing regimen highlights innovation at the clinical level.

  5. Regulatory & Policy Contributions
    As a national GCP/GMP inspector, he plays a pivotal role in drug trial ethics and compliance in China. He also holds leadership roles in pharmacogenomics committees, further demonstrating his commitment to public health advancement.

  6. Academic Mentorship and Editorial Work
    In addition to research, Prof. Tan contributes as a journal reviewer, co-author of four textbooks, and mentor to the next generation of scientists, reinforcing his role as a thought leader in the field.

🔍 Areas for Improvement:

  1. International Visibility
    While Prof. Tan’s national presence is remarkable, further international collaborations, invited keynotes at global conferences, or leading roles in global consortia could enhance his visibility and expand the influence of his work.

  2. Broader Publication Range
    Publishing more frequently in top-tier international journals (e.g., Nature, The Lancet, NEJM) would increase the global academic reach of his findings.

  3. Open Science & Data Sharing
    As the field moves toward transparency, incorporating open-access publications and shared data repositories could boost both reproducibility and citations.

🎓 Education:

Professor Zhirong Tan obtained his Ph.D. from Central South University, a premier Chinese institution, where he laid the groundwork for his expertise in clinical pharmacology and pharmacogenomics. He later pursued postdoctoral research at the School of Pharmacy, University of Maryland, Baltimore, one of the top pharmaceutical research institutions in the United States. This international experience enabled him to gain a global perspective in drug metabolism, biomarker identification, and translational pharmacology. His academic training focused on cutting-edge methodologies such as metabolomics, pharmacokinetics, and precision medicine. Through continuous education and research, he has built a reputation as a highly skilled pharmacologist whose work bridges basic research and clinical applications.

💼 Experience:

With a research career spanning over two decades since 1998, Professor Zhirong Tan has led and participated in numerous national-level and provincial-level projects, including China’s National Science and Technology Major Projects. He currently holds multiple leadership positions at Xiangya Hospital, Central South University. Over the years, he has completed major research grants from NSFC, the Hunan Province, and the Ministry of Science and Technology. As a GCP and GMP inspector, Prof. Tan has overseen more than 300 clinical trials, ensuring drug development meets regulatory and ethical standards. His experience also extends to industry collaboration, with successful execution of 5 “Million+” funded projects and influential roles in pharma-academic alliances. A frequent peer reviewer and contributor to international journals, his work influences both the scientific community and regulatory frameworks.

🔬 Research Focus:

Professor Tan’s primary research focus lies in clinical pharmacology, pharmacogenomics, and metabolomics, particularly for colorectal cancer and Alzheimer’s disease. His work aims to identify and validate biomarkers for disease diagnosis, drug efficacy, and toxicity prediction. A major contributor to China’s “Major New Drug Development” initiative, he has developed personalized esomeprazole dosing regimens by studying genetic polymorphisms, SNPs, and microRNA interactions. His research also explores the pathogenesis of Alzheimer’s disease using metabolomic profiling, offering insights into early detection and potential therapeutics. He applies advanced bioanalytical methods to understand inter-individual variability in drug metabolism and therapeutic response. His projects have real-world clinical implications, transforming how drugs are prescribed, regulated, and monitored. Through his pioneering work, Prof. Tan contributes significantly to the evolution of precision medicine in China.

📚 Publication Top Notes:

  1. 📊 Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

  2. ❤️ Gly389Arg polymorphism of β1‐adrenergic receptor and cardiovascular response to metoprolol

  3. 💊 CYP2C19 ultra-rapid metabolizer genotype affects voriconazole pharmacokinetics

  4. 🧬 HLA‐B35:01 allele as biomarker for Polygonum multiflorum–induced liver injury*

  5. 🌿 Repeated berberine administration inhibits cytochromes P450 in humans

  6. 💉 Effect of SLCO1B1 polymorphism on pharmacokinetics of nateglinide

  7. 🧪 Assessment of cytochrome P450 activity by five‐drug cocktail approach

  8. ☕ Plasma caffeine metabolite ratio linked to CYP1A2 polymorphisms

  9. 🔬 Inducibility of CYP1A2 by omeprazole associated with genetic polymorphism

  10. 🧫 Ile118Val polymorphism of CYP3A4 affects simvastatin lipid-lowering efficacy

📝 Conclusion:

Professor Zhirong Tan is a highly deserving candidate for the Best Researcher Award. His record of scientific excellence, clinical innovation, and regulatory leadership clearly positions him as a key contributor to modern pharmacology. His integrated approach—spanning basic science, clinical trials, and health policy—has had a measurable impact on patient care and drug development in China.

While there is room to further expand his global footprint, his accomplishments to date already demonstrate the caliber, commitment, and consistency expected of a world-class researcher.

Khirod Kumar Sahoo | Plant Biotechnology | Best Researcher Award

Posted on by sciencefather

Dr Khirod Kumar Sahoo |  Plant Biotechnology | Best Researcher Award

Ravenshaw University, Cuttack,  India

Dr. Khirod Kumar Sahoo is an esteemed Assistant Professor in the Department of Botany at Ravenshaw University, Cuttack, with over 14 years of research experience. His work primarily focuses on plant biotechnology and molecular biology, including the development of transgenic rice for salinity and drought tolerance. He has a robust publication record with more than 26 peer-reviewed international journal articles and holds 2 national patents.

Profile:

Education:

  • Ph.D. in Life Sciences: ICGEB, New Delhi (2011).
  • M.Sc. in Biotechnology: North Orissa University, Odisha (2004).
  • B.Sc. in Botany (Honours): North Orissa University, Odisha (2002).

Professional Memberships:

  • Life Member, Odisha Botanical Society
  • Life Member, Indian Society of Biological Chemist
  • Member Secretary, IBSC, DBT, Govt of India

Research Guidance:

  • Ph.D. Students: 3 awarded, 1 thesis submitted, 4 ongoing
  • M.Phil Students: 5 awarded
  • M.Sc. Students: 30 completed dissertation projects

Dr. Sahoo continues to contribute significantly to the field of plant biotechnology through his research, teaching, and collaborative projects.

Plant Biotechnology Research Focus:

Dr. Khirod Kumar Sahoo’s research in plant biotechnology encompasses developing transgenic plants to enhance tolerance to environmental stresses such as salinity and drought. His notable work includes:

  1. Transgenic Rice Development:
    • Ph.D. Research: Developed salinity and drought-tolerant transgenic rice through gene pyramiding at the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, in collaboration with the School of Life Sciences, Jawaharlal Nehru University (JNU), New Delhi.
    • Postdoctoral Research: Furthered this work by developing transgenic rice with enhanced environmental stress tolerance at ICGEB.
  2. Hydroponics Cultivation:
    • Current Research: Since 2020, Dr. Sahoo has been optimizing hydroponic cultivation methods for high-yield strawberry production. This research led to a recent publication in the South African Journal of Botany.
  3. Micropropagation Techniques:
    • Developed efficient micropropagation systems for strawberry plants, resulting in a provisional patent application.
  4. Phytoremediation Studies:
    • Recent Project: Received funding from the Science and Engineering Research Board (SERB) to screen and characterize various Brassica species for phytoremediation of toxic heavy metals in industrial and mining areas of Odisha. This project aims to reduce the negative impact of heavy metals on the food chain and environment.
  5. Gene Silencing for Enhanced Yield:
    • Postdoctoral Project: Worked on enhancing grain yield in salinity-tolerant rice by silencing the cytokinin oxidase gene using RNA interference (RNAi) technology.

Research Metrics:

  • Citations: 701 (cited by 657 documents)
  • Documents: 20
  • h-index: 11

Publication Top Notes:

  • Silicon nutrition stimulates Salt-Overly Sensitive (SOS) pathway to enhance salinity stress tolerance and yield in rice
    • Gupta, B.K., Sahoo, K.K., Anwar, K., …, Pareek, A., Singla-Pareek, S.L.
    • Plant Physiology and Biochemistry, 2021, 166, pp. 593–604.
    • 31 Citations
  • Isolation of a broad spectrum antimicrobial producing thermophilic Bacillus and characterization of its antimicrobial protein
    • Ojha, P., Kar, N.P., Nayak, S., Patra, A.K., Sahoo, K.K.
    • Archives of Microbiology, 2021, 203(5), pp. 2059–2073.
    • 5 Citations
  • Artificial Intelligence and Machine Learning in Rice Research
    • Donde, R., Gouda, G., Sabarinathan, S., …, Vadde, R., Behera, L.
    • Applications of Bioinformatics in Rice Research, 2021, pp. 239–275.
    • 2 Citations
  • Identification of QTLs for high grain yield and component traits in new plant types of rice
    • Donde, R., Mohapatra, S., Yasin Baksh, S.K., …, Behera, L., Dash, S.K.
    • PLoS ONE, 2020, 15(7 July), e0227785.
    • 18 Citations
  • Enhancing trehalose biosynthesis improves yield potential in marker-free transgenic rice under drought, saline, and sodic conditions
    • Joshi, R., Sahoo, K.K., Singh, A.K., …, Pareek, A., Singla-Pareek, S.L.
    • Journal of Experimental Botany, 2020, 71(2), pp. 653–668.
    • 86 Citations

 

Hanny Chauhan | Plant molecular biology | Best Scholar Award

Posted on by sciencefather

Mr Hanny Chauhan | Plant molecular biology | Best Scholar Award

SRF at  Panjab University, India

Hanny Chauhan is currently a Ph.D. Scholar in the Department of Biotechnology at Panjab University, Chandigarh, India. Her research focuses on genome editing using CRISPR/Cas9 technology, transgenics, and plant molecular biology, with a specific interest in improving traits in Solanum tuberosum (potato).

 

Profile:

Professional Achievements:

📚 Publications: Authored multiple papers in reputed journals like Life and PeerJ, exploring topics from CRISPR vectors to gene expression under stress conditions. 🌍 Collaborations: Collaborated with researchers from institutions including the University of Minnesota and INSA, Chandigarh. 🏆 Recognition: Nominated for the Best Research Scholar Award for contributions in plant molecular biology.

Academic Focus:

Hanny Chauhan is dedicated to advancing plant biotechnology and genome editing techniques, particularly in Solanum tuberosum (potato). Her research focuses on CRISPR/Cas9-mediated genome editing, aiming to enhance disease resistance and nutrient content in plants.

Research Focus: Plant Molecular Biology

Hanny Chauhan’s research revolves around leveraging cutting-edge techniques like CRISPR/Cas9 and transgenics to advance plant molecular biology. Specifically, she investigates genetic mechanisms in Solanum tuberosum (potato), aiming to enhance traits crucial for agriculture and sustainability.

 

Publication:
  • Compendium of Plant-Specific CRISPR Vectors and Their Technical Advantages
    • Year: 2021
  • Rapid and Efficient CRISPR/Cas9-Mediated Genome Editing in Potato via Hairy Root Induction
    • Year: 2023
  • Prevention of Postoperative Acute Lung Injury (ALI) – The Anaesthetist Role
    • Year: 2015
  • Genome-Wide Identification of 2-Oxoglutarate and Fe (II)-Dependent Dioxygenase Family Genes and Their Expression Profiling under Drought and Salt Stress in Potato
    • Year: 2023
  • Genome-Wide Identification and Expression Analysis of the Broad-Complex, Tramtrack, and Bric-à-Brac Domain-Containing Protein Gene Family in Potato
    • Year: 2024
  • CRISPR/Cas9 Edited StbHLH47 Lines Exhibit Altered Expression Profiling of Iron Regulating Genes and Increased Iron Content in Solanum tuberosum
    • Year: 2024
  • Genome-Editing Advances for Disease Resistance in Plants
    • Year: 2024

 

Eric-Ivan Ngoko Tchamba | Food Processing | Best Researcher Award

Posted on by sciencefather

Mr Eric-Ivan Ngoko Tchamba |  Food Processing |  Best Researcher Award

PhD Student at  Technische Universität München, Germany

Eric-Ivan NGOKO TCHAMBA is a dedicated researcher and educator specializing in plant physiology and biotechnology. Born on September 10, 1995, in Cameroon, Eric is known for his proactive and flexible approach, as well as his strong organizational and interpersonal skills. Eric’s academic journey began with a Bachelor of Science in Crop Production from the University of Bamenda, Cameroon (2013-2016). He then earned a Master of Science in Plant Physiology and Biotechnology from the University of Dschang, Cameroon (2016-2018). His master’s thesis and academic excellence earned him the recognition of being the fifth-best student in the Plant Biology department in 2018.

Profile:

🎓 Education:

Master of Science in Plant Physiology and Biotechnology 📍 University of Dschang, Cameroon | 01/10/2016 – 04/08/2018 Bachelor of Science in Crop Production 📍 University of Bamenda, Cameroon | 02/09/2013 – 01/08/2016 Baccalaureat of Mathematics and Life Science and Earth (Serie D) 📍 Government Bilingual High School Bafoussam, Cameroon | 04/09/2008 – 01/06/2012

💼 Work Experience:

Researcher Biotechnology of Natural Substances
📍 Freising, Germany | 01/02/2021 – 04/02/2023

  • LC-MS for polyphenolic, tannin, and flavonoid compounds determination
  • HPLC for sugar and carotenoid analysis
  • Plant secondary metabolites extraction
  • Antioxidant activity determination
  • Enzyme activity and biochemical activity determination
  • Laboratory safety and efficiency

Teacher
📍 National Higher Polytechnic Institute, Bambili, Cameroon | 02/10/2018 – 01/09/2021

  • Taught “Introduction to Bioengineering” to semester 4 computer science students
  • Supervised research topics on current bioengineering findings
  • Evaluated student performance

Researcher
📍 Fraunhofer Institute for Process Engineering and Packaging IVV, Freising, Germany | 01/03/2022 – 31/01/2023

  • Developed edible coating recipes to delay fruit and vegetable decay
  • GC-MS for aroma profile analysis
  • HPLC for carotenoids and sugar determination
  • Monitored ethylene, CO2, and O2 levels
  • Conducted physiological weight loss and color measurements
  • Analyzed food texture and plant hormone activities on fruits
  • Performed microscopic observations and data analysis

Scientific Laboratory Technician
📍 University of Dschang, Cameroon | 01/10/2017 – 01/08/2020

🏅 Honours and Awards

Fifth Best Student in the Plant Biology department, University of Dschang (2018)

Food Processing Research Focus:

Eric-Ivan NGOKO TCHAMBA is a dedicated researcher with a robust focus on food processing, particularly concerning post-harvest treatment strategies and the enhancement of the physical and biochemical quality parameters of fruits and vegetables. His work aims to improve food shelf life, nutritional value, and overall quality through innovative biotechnological solutions.

Publication Top Notes:

  • Title: The Combined Effect of Lemon Peel Extract and Calcium Chloride on the Physical and Biochemical Quality Parameters of the Dessert Banana (Musa acuminata var. Dwarf Cavendish) Fruit
  • Journal: Agriculture
  • Publication Date: 2024-01-30
  • DOI: 10.3390/agriculture14020222
  • Contributors: Eric-Ivan Ngoko Tchamba; Thorsten Tybussek; Peter Muranyi; Victor Francois Nguetsop; Jean Aghofack-Nguemezi; Wilfried Schwab